|
|
OJHAS: Vol. 5, Issue
3: (2006 Jul-Sep) |
|
|
Growth suppression
of antibiotic-resistant Salmonella
typhimurium DT104 by a non-DT104 strain in vitro |
|
|
Ngwai YB Department
of Microbiology, Human Virology and Biotechnology, National Institute
for Pharmaceutical Research and Development, P.M.B. 21 Garki, Abuja,
Nigeria Adachi Y Animal
Health Laboratory, School of Agriculture, Ibaraki University, 3-21-1
Ami-chou, Ami-machi, Ibaraki-ken, 300-0393, Japan
Ogawa Y Animal
Health Laboratory, School of Agriculture, Ibaraki University, 3-21-1
Ami-chou, Ami-machi, Ibaraki-ken, 300-0393, Japan |
|
|
|
|
|
Address For Correspondence |
|
Dr.
Yakubu B. Ngwai Department
of Microbiology, Human Virology and Biotechnology, National
Institute for Pharmaceutical Research and Development, P.M.B. 21
Garki, Abuja, NIGERIA.
E-mail:
ybngwai@yahoo.com |
|
|
Ngwai YB, Adachi Y, Ogawa Y. Growth suppression
of antibiotic-resistant Salmonella
typhimurium DT104 by a non-DT104 strain in vitro.
Online J Health Allied Scs.2006;3:4 |
|
Submitted: Mar 30,
2006; Revised: Oct 14,
2006; Accepted: Oct 18, 2006; Published: Dec 7, 2006 |
|
|
|
|
|
|
|
|
Abstract: |
Growth suppression
of antibiotic-resistant Salmonella typhimurium DT104 by
a non-DT104 strain was investigated in vitro. Chromosomal mutants of
eight antibiotic-resistant DT104 strains were generated by sub-culturing
on desoxycholate hydrogen sulfide lactose agar containing 25 µg/ml
of nalidixic acid. Low counts of each of these mutants (designated as
“minority cultures”) were inoculated into 24-h cultures of a non-DT104
S. typhimurium strain (designated as “majority culture”)
to test the ability of the majority culture to suppress the multiplication
of the minority culture. Multiplication of small numbers of the antibiotic-resistant
DT104 strains was significantly (P < 0.05) prevented when
the DT104s were added to 24-h brain heart infusion cultures of the non-DT104
strain. This observation has practical implications for the control
of the menacing antibiotic-resistant Salmonella typhimurium
DT104.
Key Words:
Salmonella typhimurium DT104; non-DT104; growth suppression. |
|
The present
interest in bacterial competition arose out of previous reports that
intestinal colonization of newly hatched chickens by a Salmonella
strain prevented colonization by a second Salmonella
strain inoculated 24 h later.(1,2) The inhibition was specific and
not induced by colonization with bacteria from other related genera
or by killed salmonellae. An in vitro model of the phenomenon was developed
in which 24-h nutrient broth cultures of Salmonella enterica
serovar Typhimurium (S. typhimurium)
were inoculated with small numbers of a nalidixic acid-resistant (Nalr)
mutant of the same strain and then further incubated. It was found that
the growth of the S. typhimurium
Nalr mutant was inhibited by Salmonella
cultures but not by those of other genera (1); and that the effect was
directly related to the high bacterial density.(3)
Most
studies on bacterial suppression have been done with S. typhimurium.
This serotype is a useful model since it remains the most frequently
isolated serotype of Salmonella in human, swine, avian, and bovine
salmonellosis.(4,5) Since the early 1990s, an emergent strain S.
typhimurium DT104 notable for its multiple antibiotic resistance
and wide host range has been increasingly isolated.(6-9) In addition,
this strain is thought to be more virulent than the other Typhimurium
strains.(10,11) Thus, there is urgent need to investigate into new
ways to contain this strain. In this study, we applied the principle
of bacterial competition to study the ability of stationary phase cultures
of a non-DT104 strain to suppress the growth of clinical DT104s strains
inoculated into it as nalidixic acid-resistant mutants. To our knowledge,
no similar study with DT104 has been reported before now.
Bacterial
isolates
Eight antibiotic-resistant
clinical isolates of the S. typhimurium DT104 from human
and cattle sources were used in this study. The human strains were isolated
in the United States while the cattle isolates of DT104 and the non-DT104
(S. typhimurium L1388) chicken strain were isolated in
Japan. Both strain types were kindly provided by Dr. Kazumitsu TAMURA
(formerly of the National Institute of Infectious Disease, 1-23-1, Toyama,
Shinjuku, Tokyo, 102-8640, Japan). Relevant characteristics of the isolates
are as shown in Table 1. Spontaneous nalidixic acid-resistant (Nalr)
mutants were produced by a method described previously.(12) Previous studies
indicated that this mutation had no effect on intestinal colonization or on in
vitro or in vivo inhibition of multiplication.(1,3,13)
Culture
media
All broth cultures
were propagated for 24 h in 5-ml volumes of brain heart infusion broth
(BHIB: BBL, U.S.A.) in a shaking (65 rpm) water-bath maintained at 37oC.
Viable bacterial counts were made by plating decimal dilutions on desoxycholate
hydrogen sulfide lactose agar (DHL: Nissui Co. Ltd., Japan) containing
nalidixic acid (25 µg ml-1). Nalidixic acid was purchased from Wako
Chemical Company, Japan.
Growth
Suppression Assay
Inter-phage
growth suppression of DT104 strains was tested as described previously
by Nogrady et al.(14) with certain modifications. Stationary BHIB cultures
of a non-DT104 strain (designated “majority culture”, because higher
inoculum size of it was used in the study) were inoculated with stationary
BHIB culture of DT104 strains diluted in normal saline (designated “minority
culture”, because lower inoculum size of it was used in the study).
The minority culture possessed a different antibiotic resistance marker
from the experimental strain. Growth suppression ability of the investigated
(majority) non-DT104 culture was tested by determining the growth of
the (minority) DT104 strains 1 day after inoculation, using serial dilutions
and plating onto the agar plates containing the appropriate antibiotic.
Briefly, chromosomal nalidixic acid-resistant (Nalr) mutants
of DT104s were generated by sub-culturing on DHL agar containing 25
µg/ml of nalidixic acid. Each of these mutants, designated as “minority
cultures”, and the investigated (“majority culture”) non-DT104
culture were separately grown in BHIB (37oC, shaking at 65
rpm) for 24 h. The colony forming units (CFU) per ml of both the minority
and majority cultures were determined after appropriate dilution of
0.5-ml samples in normal saline and 24-h incubation at 37oC
on DHL- 25 µg ml-1 Nalidixic acid and antibiotic-free DHL
agar respectively. 0.5 ml of diluted (1:105) minority culture
was mixed with 4.5 ml of the majority culture and re-incubated for 24
h at 37oC with shaking. The CFU of the minority culture was
determined after appropriate dilution of 0.5-ml samples of the mixed
culture in normal saline and 24-h incubation at 37oC on DHL-25
µg ml-1 Nalidixic acid.
Statistical
Analysis
Data were analyzed
by the one-way analysis of variance (ANOVA) using Smith’s Statistical
Package Version 2.5 (Gary Smith, August 30, 2001, Pomona College,
Clairemont, California, U. S. A. Significance of results was determined
at the 5 % probability level (that is, at P = 0.05)
Suppression
of growth by 24-h BHIB broth culture of non-DT104
Multiplication
of small numbers of the antibiotic-resistant DT104s was significantly
prevented when the DT104s were added to 24-h brain heart infusion cultures
of the non-DT104 strain.
Table 1:
Sensitivity of test strains to common antibiotics
Strains |
Source |
Country
of isolation |
Minimum
inhibitory concentration (MIC) in µg ml-1 |
Resistance |
A |
T |
C |
F |
G |
K |
S |
Su |
TMP |
NA |
306-98 |
Human |
CDC (U.S.A) |
>512 |
128 |
256 |
64 |
1 |
2 |
512 |
>512 |
0.5 |
4 |
ACFSSuT |
T980018 |
Human |
CDC (U.S.A) |
>512 |
64 |
256 |
64 |
0.5 |
2 |
256 |
>512 |
0.5 |
4 |
ACFSSuT |
T980021 |
Human |
CDC (U.S.A) |
>512 |
256 |
256 |
128 |
1 |
2 |
>512 |
>512 |
1 |
4 |
ACFSSuT |
T980042 |
Human |
CDC (U.S.A) |
>512 |
64 |
256 |
64 |
1 |
2 |
128 |
>512 |
0.5 |
4 |
ACFSSuT |
T980043 |
Human |
CDC (U.S.A) |
>512 |
128 |
256 |
64 |
1 |
2 |
256 |
>512 |
0.5 |
4 |
ACFSSuT |
ST3 |
Cattle |
Japan |
1 |
2 |
8 |
8 |
0.5 |
2 |
128 |
>512 |
0.5 |
4 |
SSu |
ST4 |
Cattle |
Japan |
>512 |
128 |
256 |
64 |
1 |
2 |
256 |
>512 |
0.5 |
4 |
ACFSSuT |
ST41 |
Cattle |
Japan |
1 |
2 |
8 |
8 |
0.5 |
2 |
256 |
>512 |
0.5 |
4 |
SSu |
ST
L1388 |
Chicken |
Japan |
1 |
2 |
8 |
8 |
0.5 |
2 |
32 |
64 |
0.5 |
4 |
SSu |
A, ampicillin;
T, tetracycline; C, chloramphenicol; F, florfenicol; G, gentamicin;
K, kanamycin; S, streptomycin; Su, sulfamethoxazole; TMP, trimethoprim;
and NA, nalidixic acid. ST L1388, Salmonella typhimurium
L1388. MIC was determined as described by the 1996 guidelines of National
Committee for Clinical Laboratory Standards, USA. |
Table
2: Growth suppression of Salmonella
typhimurium DT104 strains by 24-h cultures of a non-DT104 strain
DT104 isolates (Minority
Culture) |
Bacterial
CFU ml-1 relative to mixing ( ± SD) |
Statistics
(ANOVA) |
Before ( x 109) |
After (
x 105) |
306-98 |
2.10 ± 0.54 |
2.00 ± 0.00 |
P = 0.0012 |
T980018 |
1.73 ± 0.48 |
16.00 ± 5.00 |
P = 0.0086 |
T980021 |
1.70 ± 0.26 |
3.00 ± 2.00 |
P = 0.0033 |
T980042 |
2.50 ± 1.08 |
6.00 ± 5.00 |
P = 0.0161 |
T980043 |
2.08 ± 0.64 |
5.00 ± 2.00 |
P = 0.0028 |
ST3 |
1.45 ± 0.35 |
1.00 ± 0.00 |
P = 0.0285 |
ST4 |
1.85 ± 0.25 |
1.00 ± 0.00 |
P = 0.00006 |
ST41 |
2.20 ± 0.37 |
2.00 ± 0.00 |
P = 0.0014 |
The competitive
behavior of bacterial populations even within the same genera is poorly
understood. It has been proposed that microbial competition is responsible
for the predominance of S. enterica serovar Enteritidis
over S. enterica serovar Gallinarum in Europe.(15) However, that
competition is unlikely to be related directly to the one described in this
study which requires high bacterial densities to be present in the gut.
Although well studied, the basis of this mechanism of competition is also not
understood.
When the
suppression of DT104s by a non-DT104 was studied, we observed that the
multiplication of small numbers of the antibiotic-resistant DT104s was
significantly prevented when the DT104s were added to 24-h brain heart infusion
cultures of the non-DT104 strain. This observation is not new with bacteria as
reduction in the rate of bacterial multiplication in broth cultures toward the
end of logarithmic phase has been documented for many years.(16-18) However,
the interesting thing about our observation with DT104 is that of the ability of
a high density (majority) culture of antibiotic-sensitive non-DT104 strain to
suppress growth of the low density (minority) culture of multi-drug resistant
DT104.
For studying
the behavior of cultures at different phases of the growth cycle, the
system of inoculating broth cultures with small numbers of antibiotic-resistant
mutants as indicator strains appears to be useful, as found previously.(2,19,20) The method ensured that with appropriate isogenic mutants,
there was essentially no difference, other than that indicated by the
mutation, between the majority culture and the minority indicator cells,
enabling their behavior to be monitored under different conditions.
The method can also be applicable for non-isogenic mutants as shown by our
study.
Although the
present study did not investigate the factors responsible for the growth
suppression observed in the 24-h cultures of non-DT104, results of several
experiments with bacteria have indicated high cell density of the inhibiting
strain(3), nutrient shortage(21), low pH resulting from fermentation
of carbohydrates(22), reduced oxygen concentration(23), and presence
of a diffusible but labile chemical mediator (17) as possible factors.
In conclusion,
the multiplication of small numbers of the antibiotic-resistant DT104s
significantly prevented when the DT104s were added to 24-h brain heart
infusion cultures of the non-DT104 strain deserves to be re-examined
using a larger number of both DT104 and non-DT104 isolates. In addition,
the specific factor responsible for the growth suppression will need
to be further investigated. A favorable outcome, as observed from the
results of this study, will find relevance in the design of a control
measure
We gratefully
acknowledge the award of an 18-month Bishop William’s Fellowship from
Rikkyo University, Nishi-Ikebukuro, Tokyo, Japan to Y.B. Ngwai
- Barrow PA, Tucker
JF, Simpson JM. Inhibition of colonization of the chicken alimentary
tract with Salmonella typhimurium by Gram-negative facultatively
anaerobic bacteria. Epidemiology and Infection 1987;98:311-322.
- Berchieri A Jr.,
Barrow PA. Further studies on the inhibition of colonization of the
chicken alimentary tract with Salmonella typhimurium
by pre-colonization with an avirulent mutant. Epidemiology and Infection
1990;104:427-441.
- Berchieri A Jr.,
Barrow PA. In vitro characterization of intra-generic inhibition of
growth in Salmonella typhimurium. Journal of General Microbiology
1991;137:2147–2153.
- Schwartz KJ. Salmonellosis.
In Straw DE, D`Allaire S, Mengeling WL, et al, editors. Diseases of
Swine. 8th ed. Ames: Iowa State University Press; 1999. p.
535-51.
- WHO. Drug-resistant
Salmonella. World Health Organization Fact sheet No. 139, revised April
2005.
- Low D, Braaten B,
van der Woude M. Fimbriae. In Neidhardt FC, Curtiss III R, Ingraham
JL, et al, editors. Escherichia coli and Salmonella
typhimurium: Cellular and Molecular Biology. Washington DC: American
Society for Microbiology Press; 1996. p. 146-57.
- Threlfall EJ, Ward
LR, Rowe B. Multi-resistant Salmonella typhimurium DT104
and Salmonella bacteraemia. Lancet 1998;352:287-8.
- Baggessen DL, Sandvang
D, Aarestrup FM. Characterization of Salmonella
enterica Serovar Typhimurium DT104 Isolated from Denmark and Comparison
with Isolates from Europe and United States. Journal of
Clinical Microbiology 2000;38:1581-1586.
- Sameshima T, Akiba
M, Izumiya H, Terajima J, Tamura K, Watanabe H, Nakazawa M. Salmonella
Typhimurium DT104 from Livestock in Japan. Japanese
Journal of Infectious Diseases 2000;53:15-16.
- Akkina JE, Hougue
AT, Angulo RJ, et al. Epidemiologic aspects, control, and importance
of multi-drug resistant Salmonella typhimurium DT104 in the United
States. Journal of the American Veterinary
Medical Association 1999;214:790-798.
- Szmolleny G., Kostya
A, Kovacs S, et al. Epidemiology and characterization of animal Salmonella
enterica subspecies Enterica serotype Typhimurium DT104 in Hungary.
Acta Veterinary of Hungary 2000;48:407-420.
- Smith HW, Tucker
JF. The effect of antibiotic therapy on the faecal excretion of Salmonella
typhimurium by experimentally infected chickens. Journal
of Hygiene 1975; 75: 275-292.
- Smith HW, Tucker
JF. The virulence of Salmonella strains for chickens: their excretion
by infected chickens. Journal of Hygiene 1980;84:479-488.
- Nogrady N, Imre
A, Rychlik I, et al. Growth and colonization suppression of Salmonella
enterica serovar Hadar in vitro and in vivo. FEMS Microbiology
Letters 2003;218:127-133.
- Bäumler AJ, Hargis
BM, Tsolis RM. Tracing of origins of Salmonella outbreaks.
Science 2000;287:50-52.
- Davis BD, Dulbeco
R, Elsen HN, et al. Microbiology. 2nd ed. London: Harper & Row;
1973.
- Barrow PA, Lovell
MA, Zhang Barber L. Growth Suppression in Early-Stationary-Phase Nutrient
Broth Cultures of Salmonella typhimurium
and Escherichia coli Is Genus Specific and Not Regulated by σs.
Journal of Bacteriology 1996;178:3072-3076.
- Rychlik I, Martin
G, Methner U, et al. Identification of Salmonella enterica
serovar Typhimurium genes associated with growth suppression in stationary-phase
nutrient broth cultures and in the chicken intestine. Archives of
Microbiology 2002; 178: 411-420.
- Zambrano MM, Kolter
R. Escherichia coli mutants lacking NADH dehydrogenase I have
a competitive disadvantage in stationary phase. Journal of Bacteriology
1993; 175: 5642-5647.
- Zambrano MM, Siegele
DA, Almiron M, et al. Microbial competition: Escherichia coli
mutants that take over stationary phase cultures. Science 1993;259:1757-1759.
- Graham-Smith GS.
The behavior of bacteria in fluid cultures as indicated by daily estimates
of the numbers of living organisms. Journal of Hygiene 1920;19:133-204.
- Hershey AD, Bronfenbrenner
J. On factors limiting bacterial growth. International Proceedings
Society Experimemtal Biology New York 1937;36:556-561.
- Topley WWC, Wilson
GS. Principles of bacteriology and immunity. 2nd ed. London:
Edward Arnold; 1936.
|